The first autoimmune disease to be interrogated for prediagnostic autoantibodies was T1D, in which autoantibodies against autoantigens such as insulin, GAD65, and IA2 are present approximately 4–10 years before patients require insulin replacement therapy (55). This evidence concerns the gene INS and type 1 diabetes mellitus.